EICHORCondition: Carcinoma, Non-small-Cell Lung · Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this study is to determine a safe and tolerable dose(s) of JNJ-86974680 for further research in combination with cetrelimab and radiation therapy.
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| City of Hope 1 | Newnan, Georgia, United States | Recruiting |
| Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Roswell Park Comprehensive Cancer Center | Buffalo, New York, United States | Recruiting |
| Herbert Irving Comprehensive Cancer Center Columbia University Medical Center | New York, New York, United States | Recruiting |
| Providence Portland Medical Center | Portland, Oregon, United States | Recruiting |
| Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
| Next Virginia | Fairfax, Virginia, United States | Recruiting |
| Charite Research Organisation GmbH | Berlin, Germany | Completed |
| Universitaetsklinikum Giessen und Marburg GmbH | Giessen, Germany | Recruiting |
| Severance Hospital Yonsei University Health System | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Hosp. Univ. Quiron Dexeus | Barcelona, Spain | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06116786